|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 02763962.4 (espacenet) (Federated) (European Patent Register), 20020404 | | Patent/reg. no. and date | DK/EP 1381356, 20080528 | | Publication date | 20040121 | | Priority no. and date | US 281685 P, 20010405, GB 0123571, 20011002 | | EP pub. no. and date |
EP 1381356 20040121 | | Effective date | | | Applicant/owner | Aventisub LLC, 3711 Kennett Pike, Suite 200
Greenville, Delaware 19807, US | | Applicant ref. no. | AVENT USA2001/0006 | | Inventor | WETTSTEIN, Joseph, 1 Heather Hill Way
Lebanon, NJ 08833, US | | Representative | | | Opponent | | | IPC Class | A61K 31/165 (2006.01) , A61P 25/00 (2006.01) | | Title | Anvendelse af (z)-z-cyano-3-hydroxy-but-2-enoinsyre-(4-trifluoromethylphenyl) - amide til behandling af multipel sclerose | | Int. application no. | US2002010773 | | Int. publication no. | WO2002080897 | | Related patent (certificate) | CA 2014 00005 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
